Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength

MSN
2025.11.18 11:30
portai
I'm PortAI, I can summarize articles.

Analysts from Bank of America Securities and TD Cowen have reaffirmed Buy ratings on Sana Biotechnology Inc. (NASDAQ:SANA), highlighting it as a must-buy penny stock. Bank of America's Alec Stranahan set a price target of $6.00, while TD Cowen's Marc Frahm also supports the Buy rating, emphasizing the company's strategic focus and cash strength.

Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.